| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5605654 | International Journal of Cardiology | 2017 | 8 Pages |
Abstract
This meta-analysis suggests that therapy with BAS significantly improves HDL-C, LDL-C, and glycemic markers including fasting blood glucose, HbA1c levels, while deteriorating triglyceride levels.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mohsen Mazidi, Peyman Rezaie, Ehsan Karimi, Andre Pascal Kengne,